China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report released on Monday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

NYSE CPHI opened at $0.31 on Monday. China Pharma has a 52 week low of $0.27 and a 52 week high of $2.18. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. The stock’s 50-day moving average price is $0.35 and its 200-day moving average price is $0.45.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.